Abstract:Abstract Background Rapamycin is known to be effective in suppressing senescence and the senescence-associated secretory phenotype (SASP). Therefore, it is highly expected to represent an anti-aging drug. Its anti-aging effect has been demonstrated at the mouse individual level. However, there are not many clinical findings with respect to its activity in humans. Here, we aimed to clarify the effect of rapamycin on human endothelial cells (ECs) as an in vitro model of human blood vessels. Methods Over the course of oxidative stress-induced senescence using hydrogen peroxide, we examined the effect of rapamycin on human coronary artery ECs (HCAECs). Senescence was evaluated by detecting senescence-associated β-galactosidase (SA-β-Gal) activity and the real-time PCR analysis of p16 INK4a . Furthermore, expression levels of SASP factors were examined by real-time PCR and the expression of senescence-related antigens, such as intercellular adhesion molecule-1 (ICAM-1) and ganglioside GM1, were examined by fluorescence-activated cell sorting analysis and immunostaining. The inhibitory effect of rapamycin on mTOR signaling was examined by immunoblotting. The adhesion of leukocytes to HCAECs was evaluated by adhesion assays. Endothelial–mesenchymal transition (EndMT) induced by rapamycin treatment was evaluated by real-time PCR analysis and immunostaining for EndMT markers. Finally, we checked the activation of autophagy by immunoblotting and examined its contribution to EndMT by using a specific inhibitor. Furthermore, we examined how the activation of autophagy influences TGF-β signaling by immunoblotting for Smad2/3 and Smad7. Results A decrease in SA-β-Gal activity and the suppression of SASP factors were observed in HCAECs undergoing stress-induced premature senescence (SIPS) after rapamycin treatment. In contrast, ICAM-1 and ganglioside GM1 were upregulated by rapamycin treatment. In addition, leukocyte adhesion to HCAECs was promoted by this treatment. In rapamycin-treated HCAECs, morphological changes and the promotion of EndMT were also observed. Furthermore, we found that autophagy activation induced by rapamycin treatment, which led to activation of the TGF-β pathway, contributed to EndMT induction. Conclusions We revealed that although rapamycin functions to inhibit senescence and suppress SASP in HCAECs undergoing SIPS, EndMT is induced due to the activation of autophagy.

Rapamycin Promotes the Autophagic Degradation of Oxidized Low-Density Lipoprotein in Human Umbilical Vein Endothelial Cells.

Rapamycin Inhibits Oxidized Low Density Lipoprotein Uptake In Human Umbilical Vein Endothelial Cells Via Mtor/Nf-Kappa B/Lox-1 Pathway

[Protective Effects of Autophagy Against Oxidized LDL-induced Injury in Endothelial Cells].

Rapamycin Inhibits Ox-Ldl-induced Inflammation in Human Endothelial Cells in Vitro by Inhibiting the Mtorc2/pkc/c-Fos Pathway

Rapamycin Reduces Podocyte Apoptosis and is Involved in Autophagy and Mtor/ P70S6K/4EBP1 Signaling.

Moderate Autophagy Inhibits Vascular Smooth Muscle Cell Senescence to Stabilize Progressed Atherosclerotic Plaque via the mTORC1/ULK1/ATG13 Signal Pathway

[Autophagy of Human Vascular Endothelial Cells by Oxidized Low-Density Lipoprotein: Involvement of Oxidative Stress but No Oxidized Low Density Lipoprotein-1].

The Autophagy-Lysosome Pathway: a Novel Mechanism Involved in the Processing of Oxidized LDL in Human Vascular Endothelial Cells.

ROS Promote Ox-LDL-Induced Platelet Activation by Up-Regulating Autophagy Through the Inhibition of the PI3K/AKT/mTOR Pathway

How does autophagy activation affect the apoptosis, proliferation and cycle of endothelial progenitor cells in rats?

Resveratrol Enhances Autophagic Flux and Promotes Ox-LDL Degradation in HUVECs via Upregulation of SIRT1

Ox-Lp(a) Transiently Induces HUVEC Autophagy Via an ROS-dependent PAPR-1-LKB1–AMPK–mTOR Pathway

Resveratrol Protects HUVECs from Oxidized-LDL Induced Oxidative Damage by Autophagy Upregulation via the AMPK/SIRT1 Pathway

Rapamycin promotes endothelial–mesenchymal transition during stress-induced premature senescence through the activation of autophagy

Rapamycin-mediated CD36 Translational Suppression Contributes to Alleviation of Hepatic Steatosis

Autophagy Activation by Rapamycin Before Hypoxia-Reoxygenation Reduces Endoplasmic Reticulum Stress in Alveolar Epithelial Cells.

Rapamycin Protects Cardiomyocytes Against Anoxia/Reoxygenation Injury by Inducing Autophagy Through the PI3k/Akt Pathway

Rapamycin Improves Palmitate-Induced ER Stress/nf Κ B Pathways Associated with Stimulating Autophagy in Adipocytes.

Rapamycin attenuates endothelial apoptosis induced by low shear stress via mTOR and sestrin1 related redox regulation.

Rapamycin and 3-Methyladenine Regulate Apoptosis and Autophagy in Bone-Derived Endothelial Progenitor Cells

Reducing Lipofuscin Accumulation and Cardiomyocytic Senescence of Aging Heart by Enhancing Autophagy